Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting
Go back to Abeona Therapeutics Provides Clinical Update on MPS IIIA Gene Therapy Trial at the 21st Annual ASGCT Meeting| (NASDAQ: ABEO) | Delayed: 5.72 -0.03 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.75 | 52 Week High | $9.44 | |||
| Open | $5.68 | 52 Week Low | $2.05 | |||
| Day High | $5.87 | P/E | N/A | |||
| Day Low | $5.67 | EPS | $0.00 | |||
| Volume | 1,015,430 | |||||
